Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDAQ: MRX)

An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements.

Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 08, 2025. NASDAQ: MRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

London based Marex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets in the United Kingdom, the United States, and internationally. Marex Group plc (NASDAQ: MRX) reported that its annual Total Revenue rose from over $2.35 billion in 2023 to over $2.89 billion in 2024, and that its Net Income increased from $128 million in 2023 to $204.7 million in 2024.

On August 5, 2025, NINGI Research published a report alleging, among other things, that Marex Group plc "has engaged in a multi-year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure." The report alleged, among other things, that the Company has "numerous multi-million-dollar discrepancies in intercompany receivables and loans across Marex's sprawling network of 56+ entities." The report identified examples, including "a $17 million receivable created out of thin air, a subsidiary whose reported profit was inflated by 150% in group filings before being liquidated, and an asset valued at $14.9 million that was sold to Robinhood for just $2.5 million weeks later, with no reported loss." The report further alleged the Company concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund it both controls and trades with, and that it is using the fund to generate non-cash trading profits and inflate operating cash flow by misclassifying structured note issuance as income.

Shares of Marex Group plc (NASDAQ: MRX) declined from $49.34 per share on May 13, 2025, to as low as $27.91 per share on October 07, 2025.

The plaintiff claims that between May 16, 2024 and August 5, 2025, the Defendants failed to disclose to investors that the Company sold over-the-counter financial instruments to itself, that Marex had inconsistencies in its financial statements between its subsidiaries and related parties, including as to intercompany receivables and loans, that as a result of the foregoing, Marex's financial statements could not be relied upon, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Marex Group plc (NASDAQ: MRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.